Ulcerative colitis Trials in Créteil, France
Conditions / Ulcerative colitis / Créteil, France
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06880744 | A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab | RECRUITING | PHASE3 |
| NCT02808780 | An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis | ACTIVE_NOT_RECRUITING | — |
| NCT02925338 | National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life | COMPLETED | — |
| NCT01988506 | Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases | COMPLETED | PHASE2 |
| NCT05535946 | ABTECT - Maintenance | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05507203 | ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 | COMPLETED | PHASE3 |
| NCT06052059 | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06598943 | A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis | RECRUITING | PHASE2 |
| NCT06257875 | A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT05494606 | An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice | ACTIVE_NOT_RECRUITING | — |